Language selection

Search

Patent 2096662 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2096662
(54) English Title: SYRINGE
(54) French Title: SERINGUE
Status: Term Expired - Post Grant Beyond Limit
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61M 05/28 (2006.01)
  • A61M 05/31 (2006.01)
(72) Inventors :
  • REYNOLDS, DAVID L. (Canada)
(73) Owners :
  • DUOJECT MEDICAL SYSTEMS INC.
(71) Applicants :
  • DUOJECT MEDICAL SYSTEMS INC. (Canada)
(74) Agent:
(74) Associate agent:
(45) Issued: 2004-04-20
(86) PCT Filing Date: 1991-11-13
(87) Open to Public Inspection: 1993-04-01
Examination requested: 1998-11-13
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: 2096662/
(87) International Publication Number: CA1991000409
(85) National Entry: 1993-05-12

(30) Application Priority Data:
Application No. Country/Territory Date
9024710.7 (United Kingdom) 1990-11-14

Abstracts

English Abstract


A bottomless vial (2) for forming a syringe has a strengthening bead (6) at
its
wider open end to which a combination finger grip and piston retainer can be
secured.
The bead is formed at least partly inward of the main portion of the inner
surface
of the sidewall (4) of the body, so as to reduce or eliminate projection of
the bead
beyond the main portion of the outer surface of the sidewall (4). By forming
the bead
by flaring of a reduced diameter end portion (74) of the body, this objective
can be
achieved whilst providing a flare (76) which assists insertion of the piston
and a
shoulder (84) to retain the finger grip and piston retainer (16).


Claims

Note: Claims are shown in the official language in which they were submitted.


-11-
CLAIMS:
1. A pharmaceutical vial used for forming a barrel and
a piston of a syringe after being filled by conveying it
through vial filling and capping machinery, comprising a
cylindrical glass vial body having at one end an integral
open neck and a peripheral external flange around an
outer end of the neck, a peripheral edge defining an
inner periphery of an open opposite end, and a piston of
resilient material having a cylindrical head within and
concentric with the cylindrical glass body, the piston
maintaining a slidable hermetically sealing relationship
with a main inner cylindrical surface of the body, and
being located to define a chamber of volume equal to the
nominal capacity of the vial between the piston head and
the neck of the vial, the piston having integral coupling
structure wholly within the body for subsequent
connection to a syringe plunger, and the vial being
stable when standing on the peripheral edge such that it
can be conveyed while so standing through vial filling
and capping machinery without tipping over, the body
being formed adjacent said open end with peripheral
radially extending positive retention means for
engagement with complementary configurations of a tubular
piston retaining member subsequently inserted within said
open end of the body to resist overpressure within the
body, wherein the retention means and the peripheral edge
are integral with a lower end portion of the body which
is formed at least partially inwardly of the projected
circumference of said main inner cylindrical surface so
that the retention means and the peripheral edge are
located essentially within the projected circumference of
a main cylindrical external surface of the body such as
to leave the external surface of the body free of

-12-
projections having an adverse effect on the stability of
the vial;
said vial further including a pharmaceutical product
within the chamber, a needle penetrable stopper inserted
in the neck, and an annular cap crimped over said stopper
and the flange of the neck to retain the stopper in
hermetic engagement with the neck, and including a finger
grip and piston retainer member, characterized in that
the finger grip and piston retainer member includes a
tubular member which is a press fit within the open end
of the body of the vial, and a flange at an outer end of
the tubular member providing outwardly extending finger
tabs, the tubular member being recessed in its external
surface adjacent the flange in the vicinity of the finger
tabs so as to receive the retention means inward of the
interior wall of the body.
2. A vial according to claim 1, wherein any external
extent of the retention means and the peripheral edge
beyond said projected circumference is no more than 20%
of their total radial extent.
3. A vial according to claim 2, wherein the vial has a
height which is about 4 times its diameter.
4. A vial according to claim 1, wherein the lower end
portion of the body includes a cylindrical bottom portion
which is beneath the piston, and is of reduced external
diameter, and wherein the peripheral edge is formed on a
flare of the open end of the body.
5. A vial according to claim 1, wherein the lower end
portion of the body includes a cylindrical bottom portion
which is of reduced internal and external diameter such

-13-
as to provide a peripheral shoulder between said main
inner cylindrical surface and an internal cylindrical
surface of said bottom portion, and wherein an outer
cylindrical surface of said bottom portion has an
external peripheral projection which is essentially
within the projected circumference of a main cylindrical
external surface of the body, at least one of said
shoulder and said peripheral projection forming said
retention means, and the reduction of internal diameter
of the bottom portion not being such as to prevent
insertion of the piston therethrough.
6. A vial according to any one of claims 1 - 4 wherein
the cap is provided with a concentric tubular outward
extension for receiving one of a double ended hollow
needle and an adaptor for receiving a single ended hollow
needle such that one end of the double ended needle, or a
hollow needle provided on the adaptor, can penetrate the
stopper.
7. A syringe kit, including:
(i) a first subassembly comprising:
(a) a pharmaceutical vial used for forming a
barrel and a piston of a syringe, said vial
comprising a cylindrical glass vial body having
at one end an integral open neck and a
peripheral external flange around an outer end
of the neck, a peripheral edge defining an
inner periphery of an open opposite end;
(b) a piston of resilient material having a
cylindrical head within and concentric with the
cylindrical glass body, the piston maintaining
a slidable hermetically sealing relationship
with a main inner cylindrical surface of the

-14-
body, and being located to define a chamber of
volume equal to the nominal capacity of the
vial between the piston head and the neck of
the vial, the piston having integral coupling
structure wholly within the body;
(c) a pharmaceutical filled within said vial
above said piston through the open neck of the
vial; and
(d) a needle penetrable stopper inserted in
the neck, and an annular cap crimped over said
stopper and the flange of the neck to retain
the stopper in hermetic engagement with the
neck;
(ii) a plunger engageable with said coupling means
of the piston to enable the piston to be projected toward
said neck;
said vial being stable when standing on the
peripheral edge such that it can be conveyed while so
standing through vial filling and capping machinery
without tipping over, the body being formed adjacent said
open end with peripheral radially extending positive
retention means, characterized in that the retention
means and the peripheral edge are integral with a lower
end portion of the body which is formed at least
partially inwardly of the projected circumference of said
main inner cylindrical surface so that the retention
means and the peripheral edge are located essentially
within the projected circumference of a main cylindrical
external surface of the body such as to leave the
external surface of the body free of projections having
an adverse effect on the stability of the vial.

-15-
8. The syringe kit according to claim 7, further
comprising a tubular piston retaining member inserted
within said open end of the body to resist overpressure
within the body, said tubular piston retaining member
engaging said positive retention means.
9. A pharmaceutical vial used for forming a barrel and
a piston of a syringe after being filled and capped,
comprising a cylindrical glass vial body having at one
end an integral open neck and a peripheral external
flange around an outer end of the neck, a peripheral
rounded edge defining an inner periphery of an open
opposite end, and a piston of resilient material having a
cylindrical head within and concentric with the
cylindrical glass body, the piston maintaining a slidable
hermetically sealing relationship with a main inner
cylindrical surface of the body, and being located to
define a chamber of volume equal to the nominal capacity
of the vial between the piston head and the neck of the
vial, the piston having integral coupling structure
wholly within the body for subsequent connection to a
syringe plunger, and the vial being stable when standing
on the open end of the body such that it can be conveyed
while so standing through vial filling and capping
machinery without tipping over, the body being formed
adjacent said open end with peripheral radially extending
positive retention means for engagement with
complementary configurations of a tubular piston
retaining member subsequently inserted within said open
end of the body to resist overpressure within the body,
wherein the retention means is formed by shaping a lower
end portion of the body to have a reduced internal
diameter such that the retention means is formed by an
upwardly facing shoulder at the top of the lower end

-16-
portion which projects inwardly of the projected
circumference of said main inner cylindrical surface, and
the lower end portion is located essentially within the
projected circumference of a main cylindrical external
surface of the body such as to leave the external surface
of the body free of projections having an adverse effect
on the stability of the vial;
said vial further including a pharmaceutical product
within the chamber, a needle penetrable stopper inserted
in the neck, and an annular cap crimped over said stopper
and the flange of the neck to retain the stopper in
hermetic engagement with the neck, the cap being provided
with a concentric tubular outward extension for receiving
one of a double ended hollow needle and an adaptor for
receiving a single ended hollow needle such that one end
of the double ended needle, or a hallow needle provided
on the adaptor, can penetrate the stopper, and including
a finger grip and piston retainer member, wherein the
piston retainer member includes a tubular member which is
a press fit within the open end of the body of the vial,
and a flange at an outer end of the tubular member
providing outwardly extending finger tabs, the tubular
member being recessed in its external surface adjacent
the flange in the vicinity of the finger tabs so as to
receive the retention means inward of the interior wall
of the body.
10. A vial according to claim 9, wherein a generally
cylindrical bottom portion of the body is of reduced
internal and external diameter such as to provide a
peripheral shoulder between said main inner cylindrical
surface and an internal cylindrical surface of said
bottom portion, and an outer cylindrical surface of said

-17-
bottom portion has an external periphery which is
essentially within the projected circumference of a main
cylindrical external surface of the body, said shoulder
forming said retention means, and the reduced internal
diameter of the bottom portion being insufficient to
prevent insertion of the piston therethrough.
11. A pharmaceutical vial used for forming a barrel and
a piston of a syringe after being filled and capped,
comprising a cylindrical glass vial body having at one
end an integral open neck and a peripheral external
flange around an outer end of the neck, a peripheral
rounded edge defining an inner periphery of an open
opposite end, and a piston of resilient material having a
cylindrical head within and concentric with the
cylindrical glass body, the piston maintaining a slidable
hermetically sealing relationship with a main inner
cylindrical surface of the body, and being located to
define a chamber of volume equal to the nominal capacity
of the vial between the piston head and the neck of the
vial, the piston having integral coupling structure
wholly within the body for subsequent connection to a
syringe plunger, and the vial being stable when standing
on the open end of the body such that it can be conveyed
while so standing through vial filling and capping
machinery without tipping over, the body being formed
adjacent said open end with peripheral radially extending
positive retention means for engagement with
complementary configurations of a tubular piston
retaining member subsequently inserted within said open
end of the body to resist overpressure within the body,
wherein the retention means is formed by shaping a lower
end portion of the body to have a reduced internal
diameter such that the retention means is formed by an

-18-
upwardly facing shoulder at the top of the lower end
portion which projects inwardly of the projected
circumference of said main interior cylindrical surface,
and the lower end portion is located essentially within
the projected circumference of a main cylindrical
external surface of the body such as to leave the
external surface of the body free of projections having
an adverse effect on the stability of the vial;
said vial further including a pharmaceutical product
within the chamber, a needle penetrable stopper inserted
in the neck, and an annular cap crimped over said stopper
and the flange of the neck to retain the stopper in
hermetic engagement with the neck, the cap being provided
with a concentric tubular outward extension for receiving
one of a double ended hollow needle and an adaptor for
receiving a single ended needle, or a hollow needle
provided on the adaptor, can penetrate the stopper, and
including a finger grip and piston retainer member,
wherein the piston retainer member includes a tubular
member which is a press fit within the open end of the
body of the vial, and a flange at an outer end of the
tubular member providing outwardly extending finger tabs,
the tubular member being recessed in its external surface
adjacent the flange in the vicinity of the finger tabs so
as to receive the retention means inward of the interior
wall of the body.
12. A vial according to claim 11, wherein a generally
cylindrical bottom portion of the body is of reduced
internal and external diameter such as to provide a
peripheral shoulder between said main internal
cylindrical surface and an internal cylindrical surface
of said bottom portion, anal an outer cylindrical surface
of said bottom portion has an external periphery which is

-19-
essentially within the projected circumference of a main
cylindrical external surface of the body, said shoulder
forming said retention means, and the reduced internal
diameter of the bottom portion being insufficient to
prevent insertion of the piston therethrough.
13. In a method of producing a prefilled syringe for
administering a pharmaceutical preparation, said syringe
comprising a generally cylindrical syringe body having a
neck at one end and a side wall having a bead finish at
the other end, at least a component of the preparation
filled into said body, an elastomeric closure closing the
body at the neck end and secured by a cap, and an
elastomeric piston at said other end forming a hermetic
seal with an inside surface of said side wall, needle
means for movement. relative to the cap to penetrate the
elastomeric closure, and plunger means for connection to
an outer side of the piston, the improvement wherein:
the syringe is produced by associating components,
including said plunger and said needle, with a prefilled
vial produced by:
forming said body with height to diameter ratio such
that the body is stable, and so that any outward extent
of the bead is insufficient to result in interference
such as would cause tipping, when the body is conveyed
standing on said other end through equipment for filling
and capping pharmaceutical vials;
inserting said elastomeric piston wholly within said
other end of the body to form a vial open at the neck;
and
filing said vial through said neck with said
pharmaceutical preparation component, and then applying
said elastomeric closure on said cap, whilst conveying

-20-
the vial standing on said other end through equipment for
filling and capping pharmaceutical vials.
14. A method according to claim 13, wherein the
association of other components includes engaging a
piston retainer within said other end of the vial after
filling and capping, and wherein the vial with the piston
retainer applied is heat sterilized.
15. A method according to claim 13, wherein the step of
forming said body so that any outward extend of the bead
is insufficient to result in interference such as would
cause tipping includes forming the bead to provide an
upwardly facing shoulder projecting inwardly of the wall
of the body.
16. A method according to claim 13, wherein the step of
forming said body so that any outward extent of the bead
is insufficient to result in interference such as would
cause tipping includes slightly reducing the diameter of
a bottom portion of the body, and flaring the open end of
said reduced diameter portion of the body to form said
bead.

Description

Note: Descriptions are shown in the official language in which they were submitted.


WO 92/08507 PCT/CA91 /00409
- 1 -
2U956~~
SYRINGE -
This invention relates to prefilled syringes for
use in medical or veterinary treatment.
In the applicant's published European Patent
Application 0298585, there is disclosed a syringe system
based on the concept of a "bottomless vial" in which the
conventional base of a glass vial is replaced by a rubber
piston which forms a hermetic seal with the walls of the
vial, and which has a downward extension within the vial
which can be coupled to a syringe plunger. When a plunger
is so coupled to the piston, and an adaptor is applied to
a cap of the vial, the vial is converted into a syringe.
An extremely important advantage of a syringe based upon
such a bottomless vial, as compared to conventional
prefilled syringe systems, is that it can be sterilized,
filled and capped utilizing conventional vial filling
equipment generally available and in use in the
pharmaceutical industry, rather than requiring specialized
capital intensive filling systems, and that the number of
clean room operations required in production of the product
is greatly reduced as compared with known syringe assembly
and filling systems. As described in more detail in the
above application, t.'~e system is also extremely versatile
in that the "bottomless vial" can form the basis of a wide
range of syringe delivery systems.
The very reason for the advantages of the above
system, namely that the vials can be sterilized, filled and
capped utilizing conventional vial filling machinery, is
also a limitation in certain applications, since the vials
must remain stable whilst passing through the machinery,
which in turn limits the permissible height of the vial
relative to its diameter. This problem is aggravated by
the necessity for providing a bead around the external
periphery of the bottom of the vial, both in order to

WO 92/08507 PCT/CA91 /00409
20JGGG> - 2 _
provide necessary strength to the glass and to provide
means for anchoring a component of the syringe such as a
combined piston retainer, plunger grip and plunger guide
which is applied after filling of the vial, by pressing it
over the bead. The projection of the bead, although kept
to a minimum, interacts with the beads of adjacent vials
and other obstructions in such a manner as to reduce the
stability of the vial. There are also constraints on the
shaping of the bead so as to prevent ramping effects as the
beads interact which tend to promote tipping.
Additionally, the application of the adaptor to the cap of
the vial is an additional clean-room operation which is not
required during the filling of conventional vials.
Although it is generally considered that the
inner side walls of syringes should be smooth and
unobstructed, it has now unexpectedly been found that
considerable advantages can be obtained by forming the
peripheral bead at the base of a "bottomless vial" at least
partially inwardly of an internal wall of the glass body of
the vial. This makes it possible for any external extent
of peripheral bead to be reduced or eliminated, which
improves the stability of the vial and enables its height
to diameter ratio to be somewhat increased. It is also
found that a versatile combined finger grip and plunger
guide of much simplified construction yet improved
performance can be utilized in conjunction with the
modified bead.
It is also found that in many applications it is
possible to dispense with the application of a separate
adaptor to the cap of the vial by incorporating an adaptor
into the cap structure in a manner which does not interfere
with normal operation of the conventional vial capping
machinery.
_ _. ,

WO 92/08507 PCT/CA91 /00409
- 3 - 2096662
These and other features of the invention are set
forth in the appended claims.
For a better understanding of the invention,
reference may be had to the following description of
preferred embodiments thereof, with reference to the
accompanying drawings in which:
Figure 1 is an exploded isometric view of the
components of a first embodiment the syringe;
Figure 2 is a vertical section through a vial
l0 portion of the syringe, ready for filling;
Figure 3 is a longitudinal section through an
assembled syringe, after discharge of its contents;
Figure 4 is a fragmentary longitudinal section on
an enlarged scale of a portion of the syringe shown in
Figure 3, showing a modification of the arrangement shown
in that Figure; and
Figure 5 is an enlarged vertical section through
the bead of a second embodiment of the syringe, also
showing adjacent parts of a modified piston retainer and
finger grip.
Referring to Figures 1 - 4 of the drawings, a
syringe comprises a syringe barrel in the form of a
somewhat elongated glass vial 2, of which the bottom wall
is absent apart from a slight inward projection of a
strengthening bead 6 formed at the bottom of a side wall 4
of the vial and best seen in Figure 4. In the example
shown the strengthening bead 6 also has a very slight
outward projection, but this is far smaller than would be
necessary if the bead were formed wholly externally of the
side wall 4, and may be entirely eliminated. In any event,
the outward extent of the proj ection should be insuf f icient
to prevent vials from standing very closely adjacent to one
another without sufficient space to tip. Typically the
projection will not exceed about one fifth of the total
thickness of the bead. The projection of the bead on the

i
WO 92/08507 PCT/CA91 /00409
20JG6fi~ - 4
inside should also be limited, both so that the head 10 of
a moulded rubber piston 8 can be inserted into the vial
past the projection (this is facilitated by the presence of
peripheral grooves 12 in the head between sealing lands
14), and so that a sleeve 18 of a combined finger grip,
piston stop and plunger guide 16 (henceforth referred to as
the finger grip) can be pushed past the projection whilst
remaining a snug fit within the side wall of the vial.
Insertion is facilitated by the slight flare provided at
the bottom entry to the vial body by the rounding of the
bead, and the insertion is readily mechanised.
The piston 8 is also provided with an integrally
moulded downward extension 20 which is formed with a
central cavity 23 to increase its flexibility relative to
the head 10 of the piston which is substantially solid.
The piston is dimensioned so that when it is inserted in
the vial 2, the lands 14 are compressed sufficiently to
form a hermetic seal against the interior of wall 4 whilst
permitting the piston to be moved longitudinally of the
vial. Initially, the piston is located at the bottom of
the vial (see Figure 2), with the bottom of extension 20
just within the vial so that it does not affect the ability
of the vial to stand upright on its base formed by the bead
6. The location of the fairly massive solid rubber piston
8 at the base of the vial helps stabilize the empty vial 2,
even when the height of the latter is somewhat greater
relative to its diameter than is normally required for
stability. The practical limit of the height to diameter
ratio is set entirely by the requirement that the vials can
be conveyed through a conventional vial filling and capping
machine in a sufficiently stable manner to permit reliable
operation of the machine at an acceptable speed. In the
example shown, the vial has an outside diameter of
approximately 3 cm and a height of 12.8 cm. For this
diameter a height of 14 centimetres is believed to approach
the practical limit for stability, but this ratio will vary

_. WO 92/08507 PCT/CA91 /00409
- 20966~~
somew~ ~t according to the relative wall thickness of the
vial :_~~d the weight of the piston. Provided that the
outward projection of the bead 6 is insufficient to affect
stability, so that -.~e vials can jostle without applying
5 tipping force to each other, and assuming use of a piston
generally as described, the maximum ratio attainable should
be greater than 4, but will be less than 5.
The stopper 22 and cap 24 applied by the
conventional vial filling and capping machinery may be of
conventional construction, although the stopper 22 is
preferably designed substantially to fill the neck of the
vial so as to minimize dead space above the piston when the
latter is pushed to the top of the vial (See Figure 3).
This ensures that as much as possible of the contents of a
syringe formed from the vial can be expelled by movement of
the piston.
The cap 24 is preferably modified as shown in
Figure 3 and Figure 5 . In Figure 3 , a conventional main
cap cooperates with a moulded plastic adaptor assembly
comprising an annular flange 26 within the cap, a
cylindrical extension 28 extending through the cap and a
thin diaphragm 30 closing a bottom end of the extension.
An internal thread 32, similar to that provided on
conventional syringe adaptors for receiving needles, such
as those sold under the trade-mark LUER-LOK, is formed
within the adaptor. A removable push on cap may be
provided to close the open end of the adaptor during
storage, being removed prior to use. In Figure 4, the
cylindrical extension 28 is formed integrally with the
aluminum cap, again with an internal thread 32. I have
found that the extension 28 can be accommodated by
conventional vial capping machinery, at any rate with no
more than minor modification, without interfering with the
capping process, whilst the provision of such an extension

2~9fi 66
- 6 -
enables the elimination of a separate adaptor cap, and the
additional assembly step required to apply it.
In order to convert the vial into a syringe,
either a double ended needle 34 of the blood collecting
type may be applied directly to the extension 28 (See
Figure 4 ) or an adaptor 3 6 ( See Figures 1 and 3 ) may be
provided for any needle or alternative delivery device
equipped with a standard syringe coupling so as to provide
the latter with the capability of penetrating the stopper
22, as well as the diaphragm 30 if present. The adaptor 36
has a needle 38 and external thread 40 at one end, the
needle providing the penetration function and the thread 40
engaging the thread 32, while its other end provides an
internally threaded socket 42 and coaxial spigot 44 for
forming a fluid-tight coupling to the needle or the like.
Prior to fitting the double ended needle 34, or
needle and adaptor 36, a plunger 46 is applied to the
extension 20 of the piston. The plunger has a shaft 48, of
cruciform cross-section in the example shown, an internally
threaded sleeve 50 at its one end, and an end flange 52 at
its other end. The sleeve 50 has internal multistart
threads 54, complementary to external multistart threads 56
on the extension 20. The lands between the threads 54 on
the sleeve 50 and the threads 56 on the extension 20~ both
stop short respectively of the outer end of the sleeve 50
and the inner end of the extension 20 so as to form
abutments which prevent the sleeve 50 from being screwed
tightly against the underside of the head 10 of the piston.
This means that any tilting forces applied to the plunger
are applied to the relatively flexible extension 20 and not
directly to the head 10, thus minimizing the risk of
breaking the hermetic seal between the head 10 and the
vial.
SUBSTITUTE SHEET
21, .12. 92 ~9

i
CA 02096662 2002-09-19
The plunger is formed of a hinge-forming
synthetic plastic such as a pharmaceutical grade
polypropylene, and a generally semicircular peripheral
portion 62 of the flange and is separated from the
remainder by a slot 64, remaining connected only by thin,
hinge-forming connections 66. This portion 62 provides a
f finger loop which can be pulled rearwardly, as shown by
broken lines in Figure 1, to facilitate handling of the
plunger. As a supplemental or alternative feature, a
notch 71 may be formed in the shaft 48 of the plunger, to
provide a hook by means of which the syringe may be
suspended when used in certain infusion applications.
In order to provide the various functions of
preventing total withdrawal of the piston, forming a
guide for the plunger and restricting its tilting
movements, and providing a finger grip for the user, the
combined finger grip 16 and retainer is pressed into the
bottom of the vial 2 after filling and capping of the
latter. It comprises the sleeve 18 and a peripheral
flange forming oppositely extending finger tags 68. It
is also moulded from pharmaceutical grade plastic such as
polypropylene. The sleeve 18 is a resilient press fit in
the open end of the vial 4 so that it is slightly
compressed by the internal projection of the bead 6
during insertion. Insertion of the retainer 16 may be
facilitated by moderate warming of at least the retainer
and the slight flare provided by the rounding of the bead
6 also facilitates insertion. Beneath the grips 68 of
the sleeve has shallow arcuate grooves 70 in which a
portion of the bead 6 snaps as the sleeve is pressed
home. Forces applied to the grips 68 tending to pull the
sleeve 18 away from the vial in turn tend to deform the
sleeve 18, in such a manner as to increase the grip of
the

i
CA 02096662 2002-09-19
grooves 70 on the portion of the bead thus resisting
withdrawal of the sleeve 18.
During the manufacture, the empty vials 4 are
conveyed through a conventional sterilizing station, the
piston 8 is inserted in each vial 4, and the latter is
filled and capped utilizing conventional vial filling and
capping machinery (but preferably using a modified cap as
shown in Figures 1 and 3 or Figure 5). The guide and
finger grip 16 is then pressed into the base of the vial,
which is shipped with the plunger 46 unattached. Prior
to use, the plunger 46 is screwed onto the piston, and a
needle or the like is applied to the extension 28,
utilizing an adapter 36 if necessary so as to penetrate
the stopper 22, at which point the syringe is ready for
use.
A modified configuration of the bottom end of
the vial body is shown in Figure 5, in which an
alternative approach is utilized to bringing the bead at
the bottom end substantially within the diameter of the
cylindrical vial body. Peripheral beads around the
openings of glass bodies of this type are conventionally
formed by flame softening the glass and adjusting the
positioning and profile of the bead by rolling the body
against suitable forming surfaces. In the Figure 5
embodiment, a bottom portion 74 of the body 4 is flame
softened and rolled so as slightly to reduce its diameter
over about a length of typically 5-6 mm, with a fairly
conventional out-turned rounded bead 6 formed by flaring
the bottom of this reduced diameter section. The
reduction in diameter is such that at least the greater
part of the bead is within the general diameter of the
body, but is not so great as to require excessive force
in inserting the piston. In the example shown, the
outside diameter of the bead is very slightly greater

I
CA 02096662 2002-09-19
_ g _
than the general outside diameter of the body but this
need not be so. In a typical example, the inside and
outside diameters of the main portion of the vial body
are 27 mm and 30 mm respectively, providing a wall
thickness of 1.5 mm, and the reduction in diameter at the
bottom is about 1 mm. The bead can then be formed by
flaring the bottom end of the vial without increasing the
outside diameter of the bead significantly beyond that of
the main portion of the vial, typically by no more than
0.5 mm. A significant flare 76 can be provided which
facilitates insertion of the piston despite the reduction
in diameter of the bottom of the body, and, because of
the flare, the bottom contact line 78 of the vial when
free-standing on a plane surface is substantially
coincident with the outside diameter of the main body 4
of the vial, thus maximizing stability. Juxtaposition of
the vial bodies in the event of jostling on a line will
prevent any ramping tendencies which might otherwise
occur with a flared bottom configuration of this type.
Whilst the presence of the piston after its
insertion in the vial body acts to introduce a
substantial mass which tends to stabilize the vial, the
mass of the piston relative to that of the vial body will
decrease as the height of the latter increases.
Nevertheless it will result in a smaller elevation of the
center of gravity of the assembly as the vial becomes
higher than would otherwise be the case. It is also
desirable that the vial bodies be stable without the
piston present so that they may be conveyed through a
sterilizer prior to insertion of the pistons. The
present invention is particularly valuable in this
respect since the disturbing influence of a bead at the
open end projecting beyond the diameter of the main

i
CA 02096662 2002-09-19
- 9a -
portion of the body is particularly severe under such
conditions.
In order to cooperate with the modified vial
body profile, the finger grip/retainer 16 must also be
modified. The groove 70 is replaced by a bead 80 at the
upper end of the cylindrical portion 18, which bead may
be moulded with slots 82 if necessary to facilitate
insertion, and/or the component 16 may be warmed to
facilitate insertion. The bead must retain the component
with sufficient tenacity to withstand pressures from the
piston which may be developed through pressure build-up
in the vial during normal

WO 92/08507 PCT/CA91 /00409
- 10 -
storage, although it should be noted that contact of the
piston on the bead may actually help retain it by forcing
it against the shoulder 84. Alternatively or additionally,
claws 86 may be moulded onto the component 16 to retain it
by engagement with the bead 6. If the portion 18 of the
component 16 is dimension so as to abut the lower face of
the piston, it will further assist in stabilizing the latter
and maintaining an hermetic seal.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Revocation of Agent Requirements Determined Compliant 2021-04-01
Inactive: Expired (new Act pat) 2011-11-13
Inactive: Office letter 2006-10-12
Inactive: Office letter 2006-10-12
Revocation of Agent Requirements Determined Compliant 2006-10-12
Revocation of Agent Request 2006-09-15
Inactive: IPC from MCD 2006-03-11
Grant by Issuance 2004-04-20
Inactive: Cover page published 2004-04-19
Pre-grant 2004-02-03
Inactive: Final fee received 2004-02-03
Notice of Allowance is Issued 2003-08-05
Letter Sent 2003-08-05
Notice of Allowance is Issued 2003-08-05
Inactive: Approved for allowance (AFA) 2003-07-25
Amendment Received - Voluntary Amendment 2003-07-09
Inactive: S.30(2) Rules - Examiner requisition 2003-07-03
Amendment Received - Voluntary Amendment 2003-05-26
Inactive: S.30(2) Rules - Examiner requisition 2003-04-16
Amendment Received - Voluntary Amendment 2002-09-19
Revocation of Agent Requirements Determined Compliant 2002-08-22
Inactive: Office letter 2002-08-22
Inactive: Office letter 2002-08-22
Revocation of Agent Request 2002-07-18
Inactive: S.30(2) Rules - Examiner requisition 2002-03-27
Amendment Received - Voluntary Amendment 2002-02-20
Inactive: S.30(2) Rules - Examiner requisition 2001-08-21
Inactive: Status info is complete as of Log entry date 1998-12-09
Inactive: RFE acknowledged - Prior art enquiry 1998-12-09
Inactive: Application prosecuted on TS as of Log entry date 1998-12-09
All Requirements for Examination Determined Compliant 1998-11-13
Request for Examination Requirements Determined Compliant 1998-11-13
Application Published (Open to Public Inspection) 1993-04-01

Abandonment History

There is no abandonment history.

Maintenance Fee

The last payment was received on 2003-10-29

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
DUOJECT MEDICAL SYSTEMS INC.
Past Owners on Record
DAVID L. REYNOLDS
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.

({010=All Documents, 020=As Filed, 030=As Open to Public Inspection, 040=At Issuance, 050=Examination, 060=Incoming Correspondence, 070=Miscellaneous, 080=Outgoing Correspondence, 090=Payment})


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Representative drawing 1998-11-11 1 9
Claims 2003-05-25 10 441
Claims 2003-07-08 10 448
Representative drawing 2003-07-27 1 16
Drawings 1994-05-20 4 104
Claims 1994-05-20 3 131
Abstract 1995-08-16 1 75
Description 1994-05-20 10 586
Description 1999-01-07 10 463
Claims 1999-01-07 3 119
Claims 2002-09-18 10 425
Description 2002-09-18 11 462
Claims 2002-02-19 10 467
Reminder - Request for Examination 1998-07-13 1 129
Acknowledgement of Request for Examination 1998-12-08 1 172
Commissioner's Notice - Application Found Allowable 2003-08-04 1 160
PCT 1993-05-11 20 715
Correspondence 2002-07-17 3 86
Correspondence 2002-08-21 1 12
Correspondence 2002-08-21 1 19
Fees 2003-10-28 1 32
Fees 1998-08-18 1 41
Fees 2001-10-16 1 30
Correspondence 2004-02-02 1 39
Fees 2002-10-21 1 35
Fees 1997-08-14 1 34
Fees 1999-08-29 1 28
Fees 2000-10-22 1 31
Fees 2004-10-18 1 34
Fees 2005-10-02 1 29
Correspondence 2006-09-14 2 58
Correspondence 2006-10-11 1 14
Correspondence 2006-10-11 1 20
Fees 1994-10-11 1 29
Fees 1995-10-26 1 30
Fees 1997-08-14 1 29
Fees 1996-08-11 1 33
Fees 1993-05-11 1 44